TCL Archive NCI 1980s Challenge: Matching Schientific Priorities With Resources, DeVita Says At Swearing-In August 15, 1980
TCL Archive Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products June 3, 2011
TCL Archive DCE Board Delays Decision On New Collaborative Groups In Chemoprevention November 30, 1984
TCL Archive Breast Cancer Task Force Suggests 12 New Projects For RFPs, Hears Report On Hormones January 16, 1976
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive NCI appoints Robert Young chairman of the Board of Scientific Advisors, reappoints Ellen Sigal, and names 11 new members to board. Earnest Hawk to direct NCI Office of Centers, Training and Resources. November 12, 2004
